Literature DB >> 24216100

Effect of cardiac resynchronization therapy on left ventricular diastolic function: implications for clinical outcome.

Adelina Doltra1, Bart Bijnens2, José María Tolosana3, Luigi Gabrielli4, María Ángeles Castel3, Antonio Berruezo3, Josep Brugada3, Lluís Mont3, Marta Sitges3.   

Abstract

BACKGROUND: The definition of response to cardiac resynchronization therapy (CRT) remains controversial, with variable rates of response depending on the criteria used. Our aim was to analyze the impact of CRT on diastolic function in different degrees of response, particularly in patients with positive clinical but no echocardiographic response. METHODS AND
RESULTS: In 250 CRT patients clinical evaluation and echocardiography were performed before and after CRT. Absolute response to CRT was defined as a reduction in left ventricular (LV) end-systolic volume of ≥15% at 1-year follow-up. Additionally, patients were classified into 4 subgroups according to their amount of response: extensive reverse remodeling (RR), slight RR, clinical response without RR, and neither clinical response nor RR. An improvement in estimates of LV filling pressure and a decrease in left atrial dimensions were observed only in responders to CRT. Patients with clinical but no echocardiographic response had significant improvement in E-wave and deceleration time and nonsignificant improvement in other parameters.
CONCLUSIONS: LV diastolic function improves with CRT. Clinical responders without echocardiographic response show improvement in parameters of diastolic function. That suggests that clinical-only response to CRT is secondary to a real effect of the therapy, rather than a placebo effect.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Resynchronization; clinical response; diastolic function; echocardiography

Mesh:

Year:  2013        PMID: 24216100     DOI: 10.1016/j.cardfail.2013.11.001

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  3 in total

1.  Left atrial size and function as assessed by computed tomography in cardiac resynchronization therapy: Association to echocardiographic and clinical outcome.

Authors:  Peter Bomholt Hansen; Anders Sommer; Bjarne Linde Nørgaard; Mads Brix Kronborg; Jens Cosedis Nielsen
Journal:  Int J Cardiovasc Imaging       Date:  2017-01-25       Impact factor: 2.357

2.  Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.

Authors:  Mattia Arrigo; Quynh A Truong; Jackie Szymonifka; Mercedes Rivas-Lasarte; Heli Tolppanen; Malha Sadoune; Etienne Gayat; Alain Cohen-Solal; Frank Ruschitzka; James L Januzzi; Jagmeet P Singh; Alexandre Mebazaa
Journal:  Europace       Date:  2017-11-01       Impact factor: 5.214

3.  A Novel and Simple Exercise Test Parameter to Assess Responsiveness to Cardiac Resynchronization Therapy.

Authors:  Alina-Ramona Cozlac; Lucian Petrescu; Simina Crisan; Constantin Tudor Luca; Cristina Vacarescu; Caius Glad Streian; Mihai-Andrei Lazar; Andra Gurgu; Angela Dragomir; Emilia Violeta Goanta; Radu Vatasescu; Kandara Mohamed Chahine; Ciprian Rachieru; Dragos Cozma
Journal:  Diagnostics (Basel)       Date:  2020-11-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.